Integra LifeSciences | IART - Debt



Integra LifeSciences reported $2.01B in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Abbott USD 13.44B 195M Jun/2025
AtriCure USD 77.25M 15.39M Jun/2025
Baxter International USD 10.31B 2.82B Mar/2025
Becton, Dickinson and Co. USD 19.34B 71M Jun/2025
Boston Scientific USD 11.31B 563M Mar/2025
CONMED USD 881.82M 10.33M Jun/2025
Cooper Companies USD 2.48B 107.1M Jul/2025
Dexcom USD 2.58B 78.4M Jun/2025
Edwards Lifesciences USD 699.4M 101.7M Mar/2025
Globus Medical USD 477K 443.4M Mar/2025
Hologic USD 2.52B 8.5M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 52.25B 15.62B Mar/2025
Medtronic USD 28.52B 1.91B Apr/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Smith & Nephew USD 3.32B 334M Dec/2024
Stryker USD 16.58B 201M Jun/2025
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teleflex USD 2B 9.83M Jun/2025
Zimmer Biomet Holdings USD 7.57B 396.2M Jun/2025